An Investigation of the Effects of Late-Onset Dietary Restriction on Prostate Cancer Development in the TRAMP Mouse

Toxicologic Pathology

Volumn 33, Issue 3, 2005, Pages 386-397

  Suttie, Andrew W ^a   Dinse, Gregg E ^b   Nyska, Abraham ^c   Moser, Glenda J ^a   Goldsworthy, Thomas L ^a   Maronpot, Robert R ^c  

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b Biostatistics Branch   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Diet restriction; neuroendocrine; prostate cancer; TRAMP

Indexed keywords

ANDROGEN RECEPTOR; BIOCHEMICAL MARKER; CHROMOGRANIN A; NEURON SPECIFIC ENOLASE; SOMATOMEDIN C; SYNAPTOPHYSIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CALORIC RESTRICTION; CANCER GRADING; CANCER SURVIVAL; CARCINOGENESIS; DIET RESTRICTION; EPITHELIUM CELL; EXERCISE; LOW FAT DIET; MALE; MOUSE; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE;

ADENOCARCINOMA; ANIMALS; BIOLOGICAL MARKERS; CALORIC RESTRICTION; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROENDOCRINE TUMORS; ORGAN SIZE; PHOSPHOPYRUVATE HYDRATASE; PROSTATE; PROSTATIC NEOPLASMS; SYNAPTOPHYSIN; TIME FACTORS;

EID: 18244379285     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230590930272     Document Type: Article

References (38)

1. Amling CL, Riggenburgh RH, Sun L, Moul JW, Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP, Chung AK, McLeod DG Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 2004 1;22 3 439-45
2. Asamoto M, Hokaiwado N, Cho YM, Ikeda Y, Takahashi S, Shirai T Metastasizing neuroblastomas from taste buds in rats transgenic for the Simian virus 40 large T antigen under control of the probasin gene promoter Toxicol Pathol 2001 29 3 363-8
3. Belchis D Dabbs DJ Diagnostic immunohistochemistry of pediatric small round cell tumors Diagnostic Immunohistochemistry 2002 Philadelphia Churchill Livingstone 517-35
4. Bostwick DG, Qian J, Ramnani DM Dabbs DJ Immunohistochemistry of the prostate and bladder, testis, and renal tumors Diagnostic Immunohistochemistry 2002 Philadelphia Churchill Livingstone 407-85
5. Chuang CK, Wu TL, Tsao KC, Liao SK Elevated serum chromogranin A precedes prostate-specific antigen elevation and predicts failure of androgen deprivation therapy in patients with advanced prostate cancer J Formos Med Assoc 2003 102 7 480-5
6. Cohen P, Graves HC, Peehl DM, et al Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma J Clin Endocrinol Metab 1992 75 1046-53
7. Cunha GR, Hayward SW, Wang YZ Role of stroma in carcinogenesis of the prostate Differentiation 2002 70 9-10 473-85
8. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, Walther PJ, Gannon M, Vollmer RT Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features Urology 2001 58 1 47 52
9. Dunn SE, Hardman RA, Kari FW, Barrett JC Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs Cancer Res 1997 57 2687-93
10. Foster BA, Giingrich JR, Kwon ED, Madias C, Greenberg NM Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model Cancer Res 1997 57 3325-30
11. Garabedian EM, Humphrey PA, Gordon JI A transgenic mouse model of metastatic prostate cancer origination from neuroendocrine cells Proc Natl Acad Sci 1998 95 15382 7
12. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenburg NM Metastatic prostate cancer in a transgenic mouse Cancer Res 1994 56 4096 102
13. Giovannucci E Epidemiologic characteristics of prostate cancer Cancer 1995 75 1766-77
14. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM Prostate cancer in a transgenic mouse Proc Natl Acad Sci USA 1995 92 3439-43
15. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM, Matusik RJ The rat probasin gene promoter directs hormonally and developmentally regulated expresion of a heterologous gene specifically to the prostate in transgenic mice Mol Endocrinol 1994 8 230-9
16. Grimberg A, Cohen P Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis J Cell Physiol 2000 183 1 9
17. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H Inhibition of prostate carcinogenesis in TRAMP mice by oral infustion of green tea polyphenols Proc natl Acad Sci 2001 98 18 10350 5
18. Hubert M-F, Laroque P, Gillet J-P, Keenan KP The effects of diet, ad libitum feeding, and moderate and severe dietary restriction on body weight, survival, clinical pathology parameters, and cause of death in control Sprague–Dawley rats Toxicol Sci 2000 58 195 207
19. Jemal A, Thomas A, Murray T, Thun M Cancer statistics, 2002 CA Cancer J Clin 2002 52 23 47
20. Kaplan EL, Meier P Nonparametric estimation from incomplete observations J Amer Stat Assoc 1958 53 457-81
21. Kaplan-Leftko PJ, Chen T-M, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenburg NM Pathology biology of autochthonous prostate cancer in a pre-clinical transgenic mouse model The Prostate 2003 55 219-37
22. Kari FW, Dunn SE, French JE Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction J Nutr Health Aging 1999 3 92 101
23. Karr JF, Kantor JA, Hand PH The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line Cancer Res 1995 55 2455-62
24. Lee MM, Gomez SL, Chang JS, Wey M, Wang R-T, Hsing AW Soy and isoflavone consumption in relation to prostate cancer risk in China Cancer Epidemiol, Biomarkers Prevention 2003 12 665-8
25. Martiniello-Wilks R, Dane A, Mortensen E, Jeyakumar G, Wang XY, Russell PJ Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies Anticancer Res 2003 23 2633-42
26. Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Capriolo RM, Tsukamoto T, Shappell SB, Matusik RJ A Probasin-Large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential Cancer Res 2001 61 2239-49
27. Moore MG, Wetterau LA, Francis MJ Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells Int J Cancer 2003 105 14 19
28. Neter J, Wasserman W, Kutner M Applied Linear Statistical Models 1985 2 Homewood, IL Richard D. Irwin Inc.
29. Ngo TH, Barnard RJ, Cohen P, Freedland S, Tran C, deGregorio F, Elshimali YI, Herber D, Aronson WJ Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis Clin Cancer Res 2003 9 7 2734-43
30. Nyska A, Dayan A, Maronpot RR New tools in therapeutic research–prostatic cancer and models Toxicologic Pathology 2002 30 2 283-7
31. Nyska A, Suttie A, Lomnitski L, Bakshi S, Grossman S, Bergman M, Ben-Shaul V, Crocket P, Haseman JK, Moser G, Goldsworthy T, Maronpot RR Slowing tumorigenic progression in tramp mice and prostatic carcinoma cell lines using natural antioxidant from spinach, NAO—a comparative study of three antioxidants Toxicol Pathol 2003 31 39 51
32. Pugh TD, Oberley TD, Weindruch R Dietary intervention at middle age: caloric restriction but no dehydroepiandrosterone sulfate increases lifespan and lifetime cancer incidence in mice Cancer Research 1999 59 1642-8
33. Raghow S, Kuliyev E, Steakley M, Greenberg N, Steiner MS Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model Cancer Res 2000 60 4093-7
34. Shibata MA, Ward JM, Devor DE, Liu ML, Green JE Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations Cancer Res 1996 56 4894 903
35. Suttie A, Nyska A, Haseman JK, Moser GJ, Hackett TR, Goldsworthy TL, Maronpot RR A grading scheme for the assessment of proliferative lesions in the mouse postate in the TRAMP Model Toxicol Pathol 2003 31 31 38
36. 1 mice and recommended sectioning of male accessory sex organs Toxicol Pathol 2002 30 228-34
37. U.S. Department of Health and Human Services Guide for the Care and Use of Laboratory Animals 1996 Washington, DC National Academy Press
38. Wechter WJ, Leipold DD, Murray ED Jr, Quiggle D, McCracken JD, Barrios RS, Greenberg NM E-7869 (R-Flurbiprofen) Inhibits Progression of Prostate Cancer in the TRAMP mouse Cancer Res 2000 60 2203-8